WADDILL WILLIAM D. sold 12.9% of their position (8.37K shares) of ARROWHEAD PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $566.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/23/2025ACC: 0001553338-25-000005
Director
Since Jan 2019
-8.37K
Net shares
Net seller
$566.0K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
8.37K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−2.42K
Price / share
$66.66
Trade value
$161.05K
% of position
3.7%
12/19/2025
64.93K→62.51K
Common Stock
Direct
Shares
−5.45K
Price / share
$68.01
Trade value
$370.72K
% of position
8.7%
12/19/2025
62.51K→57.06K
Common Stock
Direct
Shares
−500.00
Price / share
$68.53
Trade value
$34.27K
% of position
0.9%
12/19/2025
57.06K→56.56K
Total
Net shares
−8.37K
Net value
-$566.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2025 | S · Sale | −2.42K | $66.66 | $161.05K | 3.7% | 64.93K | 62.51K |
| Common Stock Direct | 12/19/2025 | S · Sale | −5.45K | $68.01 | $370.72K | 8.7% | 62.51K | 57.06K |
| Common Stock Direct | 12/19/2025 | S · Sale | −500.00 | $68.53 | $34.27K | 0.9% | 57.06K | 56.56K |
| Total | −8.37K | -$566.04K | ||||||
Derivative Transactions0
No derivative transactions reported